Research suggests BPC-157 supports tissue repair, inflammation reduction, and cellular regeneration basically, it helps your body remember how to heal efficiently again
Our medical experts in Minnetonka will review your specific health markers to confirm that BPC-157 is appropriate for you and to establish the correct dosage for your unique physiology
This peptide has been shown to accelerate the healing of wounds, tendons, and ligaments, reduce inflammation, and protect organs, including the heart and stomach
Finished OROS batches undergo analytical verification prior to release to support quality, consistency, and transparency
Duration of use typically ranges from 4-8 weeks for acute conditions to 6-8 weeks or longer for chronic plantar fasciitis
Its compounding status has been unsettled and repeatedly revised: the FDA placed ipamorelin (with CJC-1295) on the Category 2 "do not compound" bulks list in October 2023 citing insufficient safety data